These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14977116)

  • 1. Efficacy of VectoBac (Bacillus thuringiensis variety israelensis) formulations for mosquito control in Australia.
    Russell TL; Brown MD; Purdie DM; Ryan PA; Kay BH
    J Econ Entomol; 2003 Dec; 96(6):1786-91. PubMed ID: 14977116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of VectoLex (Bacillus sphaericus) products to selected Australian mosquito and nontarget species.
    Brown ID; Watson TM; Carter J; Purdie DM; Kay BH
    J Econ Entomol; 2004 Feb; 97(1):51-8. PubMed ID: 14998127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory evaluation of biotic and abiotic factors that may influence larvicidal activity of Bacillus thuringiensis serovar. israelensis against two Florida mosquito species.
    Nayar JK; Knight JW; Ali A; Carlson DB; O'Bryan PD
    J Am Mosq Control Assoc; 1999 Mar; 15(1):32-42. PubMed ID: 10342266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoor thermal fogging against vector mosquitoes with two Bacillus thuringiensis israelensis formulations, Vectobac ABG 6511 water-dispersible granules and Vectobac 12AS liquid.
    Yap HH; Lee YW; Zairi J
    J Am Mosq Control Assoc; 2002 Mar; 18(1):52-6. PubMed ID: 11998931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory and field evaluation of efficacy of VectoBac 12AS against Culex sitiens (Diptera: Culicidae) larvae.
    Brown MD; Thomas D; Watson K; Kay BH
    J Am Mosq Control Assoc; 1998 Jun; 14(2):183-5. PubMed ID: 9673920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of Bacillus thuringiensis H-14 formulations and pyriproxyfen for the control of larvae of Aedes aegypti and Aedes albopictus.
    Lee YW; Zairi J; Yap HH; Adanan CR
    J Am Mosq Control Assoc; 2005 Mar; 21(1):84-9. PubMed ID: 15825767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory and simulated field evaluation of a new recombinant of Bacillus thuringiensis ssp. israelensis and Bacillus sphaericus against Culex mosquito larvae (Diptera: Culicidae).
    Zahiri NS; Federici BA; Mulla MS
    J Med Entomol; 2004 May; 41(3):423-9. PubMed ID: 15185945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of liquid Bacillus thuringiensis var. israelensis products for control of Australian Aedes arbovirus vectors.
    Brown MD; Carter J; Watson TM; Thomas P; Santaguliana G; Purdie DM; Kay BH
    J Am Mosq Control Assoc; 2001 Mar; 17(1):8-12. PubMed ID: 11345425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of ULV formulations (Pesguard 102/Vectobac 12AS) against three mosquito species.
    Yap HH; Chong AS; Adanan CR; Chong NL; Rohaizat B; Malik YA; Lim SY
    J Am Mosq Control Assoc; 1997 Dec; 13(4):384-8. PubMed ID: 9474567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Bacillus thuringiensis israelensis, VectoBac WG and DT, formulations against dengue mosquito vectors in cement potable water jars in Cambodia.
    Setha T; Chantha N; Socheat D
    Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):261-8. PubMed ID: 17539275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field efficacy of granular formulations of Bacillus thuringiensis Israelensis--strain AM65-52 against floodwater mosquitoes in Poland and Germany.
    Rydzanicz K; DeChant P; Becker N
    J Am Mosq Control Assoc; 2010 Sep; 26(3):295-301. PubMed ID: 21033056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of mosquitoes in catch basins in Connecticut with Bacillus thuringiensis israelensis, Bacillus sphaericus, [corrected] and spinosad.
    Anderson JF; Ferrandino FJ; Dingman DW; Main AJ; Andreadis TG; Becnel JJ
    J Am Mosq Control Assoc; 2011 Mar; 27(1):45-55. PubMed ID: 21476447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Field evaluation of biolarvicides in Surat city, India.
    Haq S; Bhatt RM; Vaishnav KG; Yadav RS
    J Vector Borne Dis; 2004; 41(3-4):61-6. PubMed ID: 15672558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vectobac DT and culinexcombi against mosquito larvae in unused swimming pools in Malindi, Kenya.
    Kahindi SC; Midega JT; Mwangangi JM; Kibe LW; Nzovu J; Luethy P; Githure J; Mbogo CM
    J Am Mosq Control Assoc; 2008 Dec; 24(4):538-42. PubMed ID: 19181062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of temperature and concentration of VectoBac on control of the salt-marsh mosquito, Ochlerotatus squamiger, in Monterey County, California.
    Christiansen JA; McAbee RD; Stanich MA; DeChant P; Boronda D; Cornel AJ
    J Am Mosq Control Assoc; 2004 Jun; 20(2):165-70. PubMed ID: 15264626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity of selected larvicidal formulations against Anopheles stephensi Liston and Aedes aegypti Linn.
    Mittal PK; Adak T; Batra CP
    J Commun Dis; 2001 Jun; 33(2):116-20. PubMed ID: 12170930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of three microbial formulations against Culex pipiens pipiens larvae in irrigation fields in Wroclaw, Poland.
    Rydzanicz K; Lonc E; Kiewra D; Dechant P; Krause S; Becker N
    J Am Mosq Control Assoc; 2009 Jun; 25(2):140-8. PubMed ID: 19653495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Field trials of three concentrations of Laginex as biological larvicide compared to Vectobac-12AS as a biocontrol agent for Culex quinquefasciatus.
    Hallmon CF; Schreiber ET; Vo T; Bloomquist A
    J Am Mosq Control Assoc; 2000 Mar; 16(1):5-8. PubMed ID: 10757483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy studies of Vectobac 12as and Teknar HP-D larvicides against 3rd-instar Ochlerotatus taeniorhynchus and Culex quinquefasciatus in small plot field studies.
    Floore TG; Petersen JL; Shaffer KR
    J Am Mosq Control Assoc; 2004 Dec; 20(4):429-33. PubMed ID: 15669386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory and semi-field evaluation of the efficacy of
    Derua YA; Tungu PK; Malima RC; Mwingira V; Kimambo AG; Batengana BM; Machafuko P; Sambu EZ; Mgaya YD; Kisinza WN
    Curr Res Parasitol Vector Borne Dis; 2022; 2():100089. PubMed ID: 35664894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.